Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-27T08:57:10.926Z Has data issue: false hasContentIssue false
  • English
  • Français

5-HT2 neurotransmission in major depression

Published online by Cambridge University Press:  03 January 2018

R. Ramasubbu
R. Ramasubbu*
Affiliation:
University of Ottawa, Royal Ottawa Hospital, 1145 Carting, Ottawa, Ontario, K1Z 7KA Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 172 , Issue 6 , June 1998 , pp. 541
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

Aulakh, C. S. Hill, J. L. & Murphy, D. L. (1994) Lithium treatment restores Clonidines effect in an animal model of depression. Pharmacology, Biochemistry and Behavior, 47, 985–987.Google Scholar
Feder, R. (1991) Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. Journal of Clinical Psychiatry, 52, 163–164.Google Scholar
Harrison-Read, P. E. (1998) Lithium withdrawal mania supports lithium's antimanic action and suggests an animal model involving serotonin (letter). British Journal of Psychiatry, 172, 96–97.CrossRefGoogle Scholar
Hrdina, P. D. Bakish, D. Ravindran, A. et al (1997) Platelet serotonergic indices in major depression: upregulation of 5HT2A receptors unchanged by antidepressant treatment. Psychiatry Research, 66, 73–85.CrossRefGoogle ScholarPubMed
Sargent, P. A. Williamson, D. J. & Cowen, P. J. (1998) Brain 5-HT neurotransmission during paroxetine treatment. British Journal of Psychiatry, 172, 49–52.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.